Social media

Artificial intelligence is transforming how life sciences teams plan, execute, and scale commercial strategy—but the true differentiator isn’t the algorithm. It’s the data foundation behind it. In our latest blog, we ex...

The future of patient safety is being shaped today by experts who combine scientific rigour with innovation. Hassan Aljobori, Pharmacovigilance Director at ICON, discusses global collaboration, the role of emerging te...

Heart failure is one of the leading causes of hospitalisation among adults over 65. Cardiovascular outcome trials can be complex and costly. Find out how considering the human element of CVOTs, and building appropriate...

With trial complexity and costs rising, sponsors are shifting from WHETHER to use DHTs to HOW to integrate them responsibly and at scale. With regulators like the FDA and EMA actively encouraging patient-centric and real...

In this article, our data standards experts Kent Letourneau and Sandra Minjoe explain how sponsors can efficiently prepare clinical data submissions that meet both FDA and PMDA requirements, by leveraging the substantial...

PLATO 11 is a new, validated, freely accessible PRO instrument developed by ICON’s Patient Centred Outcomes and the American Academy of Sleep Medicine to fill a critical gap in patient centred assessment for obstructive ...

Latest issue out now. Keep up to date on the most recent regulatory changes in the world of pharma, biotech and medical device clinical trials with ICON’s Regulatory Intelligence Newsletter. Join thousands of subscribe...

1 in 5 people will develop heart failure in their lifetime. ICON recognises the importance to raise global awareness of heart failure risk factors such as hypertension, obesity, diabetes and coronary heart disease. Dis...

Next week ICON Biotech sponsors #OCTWestCoast! Drop by booth \#79 to speak with our experts, including Travis Caudill VP who will be giving a special featured presentation and appearing on a panel to discuss the latest A...

ICON is proud to support Heart Failure Awareness Week. As a global leader in cardiovascular trials, we remain committed to raising awareness and advancing better, safer and more cost‑effective therapies for people living...

ICON is a proud sponsor of this year’s #ISCR Annual Conference, taking place in New Dehli from 13 – 14 February. Visit the ICON team at booth #G-11 to learn about our high-quality, global services and solutions to suppor...

There is great excitement following the announcements by the FDA and EMA around streamlining the biosimilar trial process. They promise to reduce the burden on developers and therefore increase the number of more afford...